Stocksigma LogoStocksigma Logo

Granules India Outlines Long-Term Growth Engines and ₹2,000 Crore Expansion Plan

Granules India plans to invest ₹2,000 crore in organic capex over the next 3–4 years, targeting complex generics, oncology, US operations, and peptide

Granules India Outlines Long-Term Growth Engines and ₹2,000 Crore Expansion Plan

Granules India Ltd · Transcript · 06 Oct 2026, 11:00 pm

Granules India Outlines Long-Term Growth Engines and ₹2,000 Crore Expansion Plan Granules India plans to invest ₹2,000 crore in organic capex over the next 3–4 years, targeting complex generics, oncology, US operations, and peptide CDMO. Peptide CDMO entity Senn Tides targets $50m revenue in three years and over $100m in five years. Complex generics contribution reached 33% of FY26 revenue, supported by a strong first-to-file pipeline. R&D spending expanded to 6% of revenue in Q1 FY27, while ROCE rose YoY to 18%. Warrants proceeds received in Sep'26 elevated the company to a consolidated net cash position.

Original exchange filing (PDF)

More announcements from Granules India Ltd

All Granules India Ltd announcements